“Appropriate” Classification Should Be European Goal – MHRA Devices Head
This article was originally published in The Gray Sheet
Executive Summary
The European device industry is urging national competent authorities to withhold their decisions on joint implant upclassification until additional data are ready for release next month
You may also be interested in...
MHRA, Eucomed Agree Guidance Needed To Clarify Reclassification Process
Guidance on the degree of evidence required for medical device reclassification will prevent friction of the type that arose between industry and regulators during European implant policymaking, MHRA's Steve Owen suggested June 24
MHRA, Eucomed Agree Guidance Needed To Clarify Reclassification Process
Guidance on the degree of evidence required for medical device reclassification will prevent friction of the type that arose between industry and regulators during European implant policymaking, MHRA's Steve Owen suggested June 24
European Industry Decries Broad MDD Regrouping Sought By UK, France
Upclassification of artificial joint products under the Medical Devices Directive (MDD) could result in an EU market shortage of devices used in hip replacement surgery, according to European manufacturers